VKTX
Viking Therapeutics, Inc.
$26.17−0.71 (−2.64%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Apr 28, 2015 – Nov 18, 2026, Dividends reinvested
- Final balance
- $32,713
- CAGR
- +10.80%
- Max drawdown
- −90.41%
Trailing returns (%)
VKTX's average annual return was 36.68% over the last 10 years, through Nov 18, 2026. $10,000 in VKTX on Nov 18, 2016 grew to $227,565 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +3.97%
- 3M
- −21.58%
- 6M
- −8.78%
- YTD
- −25.61%
- 1Y
- −30.69%
Per year
- 3Y
- +32.42%
- 5Y
- +35.50%
- 10Y
- +36.68%
- Since 2015
- +10.80%
Annual returns
2015 from Apr 28 · 2026 through Nov 18
VKTX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −25.61% |
| 2025 | −12.57% |
| 2024 | +116.23% |
| 2023 | +97.98% |
| 2022 | +104.35% |
| 2021 | −18.29% |
| 2020 | −29.80% |
| 2019 | +4.84% |
| 2018 | +88.42% |
| 2017 | +241.18% |
| 2016 | −65.10% |
| 2015 from Apr 28 | −57.37% |
Metrics
Since 2015| Volatility | 101.05% |
|---|---|
| Sharpe ratio | 0.52 |
| Sortino ratio | 1.05 |
| Calmar ratio | 0.12 |
| Longest drawdown | 4.6 years |
Worst drawdowns
Since 2015| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −90.4% | May 2015 | Aug 2017 | May 2018 | 3.1 years |
| −89.3% | Sep 2018 | Jun 2022 | Apr 2023 | 4.6 years |
| −78.9% | Feb 2024 | Apr 2025 | Not yet | 2.7 years so far |
| −62.7% | Jun 2023 | Oct 2023 | Feb 2024 | 8 months |
| −25.5% | Jun 2018 | Jun 2018 | Aug 2018 | 2 months |